CN102715393A - Preparation method of L-carnitine effervescent tablets - Google Patents
Preparation method of L-carnitine effervescent tablets Download PDFInfo
- Publication number
- CN102715393A CN102715393A CN2012102352824A CN201210235282A CN102715393A CN 102715393 A CN102715393 A CN 102715393A CN 2012102352824 A CN2012102352824 A CN 2012102352824A CN 201210235282 A CN201210235282 A CN 201210235282A CN 102715393 A CN102715393 A CN 102715393A
- Authority
- CN
- China
- Prior art keywords
- preparation
- particle
- carnitine
- tablet
- minute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000005453 pelletization Methods 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims abstract description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 15
- 239000003826 tablet Substances 0.000 claims description 14
- 238000012856 packing Methods 0.000 claims description 12
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 10
- 235000020985 whole grains Nutrition 0.000 claims description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- 239000008188 pellet Substances 0.000 claims description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 5
- 108010011485 Aspartame Proteins 0.000 claims description 5
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 5
- 241000335053 Beta vulgaris Species 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 5
- 229960004998 acesulfame potassium Drugs 0.000 claims description 5
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 5
- 239000000619 acesulfame-K Substances 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 239000001530 fumaric acid Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 5
- 238000003556 assay Methods 0.000 claims description 3
- 238000010923 batch production Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000012937 correction Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012946 outsourcing Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 229960004203 carnitine Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a preparation method of L-carnitine effervescent tablets. The preparation method comprises the following steps: (1), material picking; (2), dosing and weighing; (3), pelletizing and drying; (4), straightening granules; (5), blending; (6), tabletting; (7), inner packaging; (8) outer packaging; and (9) putting in storage. The preparation method of L-carnitine effervescent tablets has a reasonable process, and the L-carnitine effervescent tablets prepared by the preparation method are stable and effective, and can be taken by cold water or warm water.
Description
Technical field
The present invention relates to field of food, particularly a kind of preparation method of l-cn effervescent tablet.
Background technology
L-cn (L-carnitine) is claimed L-carnitine or transliteration Carnitine again, is a kind of amino acid that impels fat to be converted into energy, and red meat is the main source of l-cn, to the human non-toxic side effect.Dissimilar diets has contained the l-cn of 5-100 milligram, but common people can only take in 50 milligrams every day from meals, and the vegetarian takes in still less.The major physiological function of l-cn is to promote that fat changes into energy; Taking l-cn can be when reducing body fat, reducing body weight; Do not reduce moisture and muscle, regarded as the safest fat-reducing nutrient complementary goods that has no side effect by international fat health tissues in 2003.L-carnitine-L-tartrate is the stable form of l-cn, and its effect and effect and l-cn are basic identical, generally is used for capsule and tablet and makes.
General fasting, vegetarian diet, strenuous exercise, obesity, pregnancy, male sterility, the crowds such as baby that eat the formula food of not strengthening carnitine lack carnitine easily.The low shortage that also causes carnitine of lysine, vitamin and iron content in the meals.Many patients such as heart disease, hyperlipemia, ephrosis, cirrhosis, malnutrition, hypothyroidism and some muscle and neurogenic disease etc., its carnitine levels is generally low.Replenishing of l-cn mainly relies on exogenous replenishing, and the importance of additional carnitine is not second to replenishing vitamins and mineral element.
Summary of the invention
The preparation method who the purpose of this invention is to provide a kind of l-cn effervescent tablet.
For realizing above-mentioned purpose, the invention provides a kind of preparation method of l-cn effervescent tablet, may further comprise the steps:
(1) neck material: press list of ingredients neck material according to producing instruction, list of ingredients is formed and weight ratio is: beet red juice powder 4-10%, FOS 8-13%; L-carnitine-L-tartrate 5-12%, citric acid 3-8%, sodium acid carbonate 3-10%; D-sorbite 25-40%, flavoring essence 1-4%, Aspartame 0.5-2%; Acesulfame potassium 5-7%, fumaric acid 3-7%, dolomol 1.5-4%;
(2) batching weighing: with the good instrument that meets clean requirement of check and correction, and use special-purpose container to weigh, post label;
(3) granulation is dry: mixed 15-25 minute claiming that the material for preparing is poured into to do in the wet granulator earlier; Make wet granular to the material that mixes by weight adding purified water 10%-18% again; Carry out drying to the wet granular that makes with boiling drier at last, obtain dried particle;
(4) whole grain: the particle that drying is good carries out whole grain with pelletizing machine;
(5) total mixing: place 12 rev/mins of efficient three-dimensional motion mixer medium speeds to particle and dolomol behind the whole grain, mixed 15-25 minute, then always mixed particle with clean utensil splendid attire, add a cover and weigh, marked label;
(6) compressing tablet: dash carrying out compressing tablet through the particle that is up to the standards with corresponding sheet, pack the sheet that presses in the satisfactory material cycling container into, it is also labelled to weigh;
(7) bag in: to packing through the sheet that is up to the standards, 20 slices/jar of packing specifications are delivered to the place that labels with the packing jar of Proper Packing by conveyer;
(8) outsourcing: decals, coding vanning;
(9) warehouse-in: the product to accords with production requires is signed and issued batch production clearance record, after the assay was approved warehouse-in.
As optimal technical scheme of the present invention, EAT is 50 ℃-75 ℃ when dry, 30-45 minute air intake time, dry good pellet moisture < 5%; Total mixed pellet moisture should be between 2.5%-5%; Tablet weight variation behind the compressing tablet is ± 4%, is no more than 1 minute disintegration time limited.
The preparation method of l-cn effervescent tablet of the present invention, technology is reasonable, and the effervescent tablet of processing is stable, effective, can take after mixing it with water with cold water or warm water.
The specific embodiment
Specify optimal technical scheme of the present invention below.
Embodiment 1
L-cn effervescent tablet provided by the invention, list of ingredients is formed and weight ratio is: beet red juice powder 9%, FOS 12%; L-carnitine-L-tartrate 10%, citric acid 6%, sodium acid carbonate 8%; D-sorbite 37%, flavoring essence 1%, Aspartame 2%; Acesulfame potassium 6%, fumaric acid 6%, dolomol 3%.
Embodiment 2
L-cn effervescent tablet provided by the invention, list of ingredients is formed and weight ratio is: beet red juice powder 10%, FOS 13%; L-carnitine-L-tartrate 11%, citric acid 5%, sodium acid carbonate 7%; D-sorbite 36%, flavoring essence 1%, Aspartame 2%; Acesulfame potassium 6%, fumaric acid 6%, dolomol 3%.
Embodiment 3
L-cn effervescent tablet provided by the invention, list of ingredients is formed and weight ratio is: beet red juice powder 8%, FOS 11%; L-carnitine-L-tartrate 9%, citric acid 7%, sodium acid carbonate 9%; D-sorbite 38%, flavoring essence 1%, Aspartame 2%; Acesulfame potassium 6%, fumaric acid 6%, dolomol 3%.
The preparation method of the foregoing description may further comprise the steps:
(1) neck material: press list of ingredients neck material according to producing instruction;
(2) batching weighing: with the good instrument that meets clean requirement of check and correction, and use special-purpose container to weigh, post label;
(3) granulation is dry: mixed 15-25 minute claiming that the material for preparing is poured into to do in the wet granulator earlier; Make wet granular to the material that mixes by weight adding purified water 10%-18% again; Carry out drying to the wet granular that makes with boiling drier at last, obtain dried particle, EAT is 50 ℃-75 ℃ when dry; 30-45 minute air intake time, dry good pellet moisture < 5%;
(4) whole grain: the particle that drying is good carries out whole grain with pelletizing machine;
(5) total mixing: place 12 rev/mins of efficient three-dimensional motion mixer medium speeds to particle and dolomol behind the whole grain; Mixed 15-25 minute, then total mixed particle with clean utensil splendid attire, add a cover and weigh; Label, total mixed pellet moisture should be between 2.5%-5%;
(6) compressing tablet: dash carrying out compressing tablet through the particle that is up to the standards with corresponding sheet, pack the sheet that presses in the satisfactory material cycling container into, it is also labelled to weigh, and the tablet weight variation behind the compressing tablet is ± 4%, is no more than 1 minute disintegration time limited;
(7) bag in: to packing through the sheet that is up to the standards, 20 slices/jar of packing specifications are delivered to the place that labels with the packing jar of Proper Packing by conveyer;
(8) outsourcing: decals, coding vanning;
(9) warehouse-in: the product to accords with production requires is signed and issued batch production clearance record, after the assay was approved warehouse-in.
L-cn, another name Cobastab t is naturally occurring a kind of compound in the human body cell.Human body synthetic l-carnitine food voluntarily also can provide a part.L-cn is the material of a kind of key in the fat metabolism process, in cell mitochondrial, makes fat carry out oxidation Decomposition and is converted into energy.Use the l-cn effervescent tablet of preparation method's preparation of the present invention; L-carnitine-L-tartrate wherein is the stable form of l-cn; Its effect and effect and l-cn are basic identical, generally are used for capsule and tablet and make, and l-cn is the material of a kind of key in the fat metabolism process; In cell mitochondrial, make fat carry out oxidation Decomposition and be converted into energy; Taking l-cn can not reduce moisture and muscle when reducing body fat, reducing body weight, regarded as the safest fat-reducing nutrient complementary goods that has no side effect in 2003 by international fat health tissues.L-cn can not only strengthen endurance, improves sports achievement, promotes fatigue recovery, and delaying senility course helps infantile health, in the health care that medically also helps heart and blood vessel, helps eliminating fatty liver, treatment haemorrhagic shock etc.FOS wherein can promote Bifidobacterium to rise in value rapidly, suppresses the growth of harmful bacteria in the enteron aisle, helps human body to safeguard good stomach environment.
The preparation method of l-cn effervescent tablet of the present invention, technology is reasonable, and the effervescent tablet of processing is stable, effective, can take after mixing it with water with cold water or warm water.
Claims (4)
1. the preparation method of a l-cn effervescent tablet is characterized in that may further comprise the steps:
(1) neck material: press list of ingredients neck material according to producing instruction, list of ingredients is formed and weight ratio is: beet red juice powder 4-10%, FOS 8-13%; L-carnitine-L-tartrate 5-12%, citric acid 3-8%, sodium acid carbonate 3-10%; D-sorbite 25-40%, flavoring essence 1-4%, Aspartame 0.5-2%; Acesulfame potassium 5-7%, fumaric acid 3-7%, dolomol 1.5-4%;
(2) batching weighing: with the good instrument that meets clean requirement of check and correction, and use special-purpose container to weigh, post label;
(3) granulation is dry: mixed 15-25 minute claiming that the material for preparing is poured into to do in the wet granulator earlier; Make wet granular to the material that mixes by weight adding purified water 10%-18% again; Carry out drying to the wet granular that makes with boiling drier at last, obtain dried particle;
(4) whole grain: the particle that drying is good carries out whole grain with pelletizing machine;
(5) total mixing: place 12 rev/mins of efficient three-dimensional motion mixer medium speeds to particle and dolomol behind the whole grain, mixed 15-25 minute, then always mixed particle with clean utensil splendid attire, add a cover and weigh, marked label;
(6) compressing tablet: dash carrying out compressing tablet through the particle that is up to the standards with corresponding sheet;
(7) bag in: to packing through the sheet that is up to the standards, 20 slices/jar of packing specifications are delivered to the place that labels with the packing jar of Proper Packing by conveyer;
(8) outsourcing: decals, coding vanning;
(9) warehouse-in: the product to accords with production requires is signed and issued batch production clearance record, after the assay was approved warehouse-in.
2. the preparation method of l-cn effervescent tablet as claimed in claim 1 is characterized in that: EAT is 50 ℃-75 ℃ when dry, 30-45 minute air intake time, dry good pellet moisture < 5%.
3. the preparation method of l-cn effervescent tablet as claimed in claim 1 is characterized in that: total mixed pellet moisture should be between 2.5%-5%.
4. the preparation method of l-cn effervescent tablet as claimed in claim 1 is characterized in that: the tablet weight variation behind the compressing tablet is ± 4%, is no more than 1 minute disintegration time limited.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102352824A CN102715393A (en) | 2012-07-09 | 2012-07-09 | Preparation method of L-carnitine effervescent tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102352824A CN102715393A (en) | 2012-07-09 | 2012-07-09 | Preparation method of L-carnitine effervescent tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102715393A true CN102715393A (en) | 2012-10-10 |
Family
ID=46941378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102352824A Pending CN102715393A (en) | 2012-07-09 | 2012-07-09 | Preparation method of L-carnitine effervescent tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102715393A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593241A (en) * | 2003-09-12 | 2005-03-16 | 深圳市海川实业股份有限公司 | Natural nutrient effervescent tablet |
| CN101439027A (en) * | 2008-12-19 | 2009-05-27 | 北京康比特体育科技股份有限公司 | Effervescent tablet containing L-carnitine-L-tartrate |
-
2012
- 2012-07-09 CN CN2012102352824A patent/CN102715393A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593241A (en) * | 2003-09-12 | 2005-03-16 | 深圳市海川实业股份有限公司 | Natural nutrient effervescent tablet |
| CN101439027A (en) * | 2008-12-19 | 2009-05-27 | 北京康比特体育科技股份有限公司 | Effervescent tablet containing L-carnitine-L-tartrate |
Non-Patent Citations (1)
| Title |
|---|
| 赵存梅等: "《药物泡腾剂技术》", 31 January 2007, 化学工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101939011B (en) | Compositions and methods for influencing recovery from strenuous physical activity | |
| CN101569412B (en) | Sports nutrition supplement and application thereof | |
| CN105495262A (en) | Double-protein-peptide anti-fatigue solid beverage | |
| JP2023009223A (en) | Nutritional supplementary food containing fruit sugar, protein with reduced molecular weight, and black pepper extract | |
| CN107047937A (en) | A kind of dog newborn nutritious calcium tablet of sheep and preparation method thereof | |
| CN102150838A (en) | Weight losing composition, preparation containing same and preparation method thereof | |
| JP2025003735A (en) | Oral composition | |
| CN102715394B (en) | L-carnitine effervescent tablet | |
| CN102613465A (en) | Nutrient powder containing potato, sweet potato, pumpkin, lotus root and water chestnut | |
| CN109925505A (en) | A kind of pressed candy | |
| CN102715393A (en) | Preparation method of L-carnitine effervescent tablets | |
| JP7329262B2 (en) | Dietary supplement containing dried sardine powder and fructan powder | |
| CN101223966A (en) | Preparing method of kiwi series food | |
| CN103478848A (en) | Acorn and lotus instant granules for strengthening body | |
| JP2004049102A (en) | Health food and method for producing the same | |
| CN101530460A (en) | Line products of alcohol-relieving and liver-protecting preparation | |
| CN101411478A (en) | Nourishing powder containing pilose antler and rice suitable for persons in middle and old age to eat and preparation method thereof | |
| CN102172287B (en) | Alkaline food containing abundant potassium and magnesium | |
| JP5027052B2 (en) | Apple-like powder composition and use thereof | |
| CN1303904C (en) | Olive calcium tablet | |
| AU2021104246A4 (en) | Slimming probiotic soft capsule and preparation method thereof | |
| CN108096281A (en) | A kind of strong blood body building composition | |
| CN109953332A (en) | A kind of rose calcium tablet and preparation method thereof | |
| CN102038194A (en) | Calcium protein powder of marine organisms | |
| CN102973543A (en) | Weight-loss effervescent tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121010 |